Kazantseva, A.V.,
Davydova, Y.D.,
Enikeeva, R.F.,
Valinurov, R.G.,
Gareeva, A.E.,
Khusnutdinova, N.N.,
Khusnutdinova, E.K. (2021) by molecular mechanisms related to the functioning of oxytocin (OXTR) and
arginine vasopressin receptor (AVPR1B
PARFENOV, E.V.,
PARFENOVA, L.V.,
MUKAEVA, V.R.,
FARRAKHOV, R.G.,
STOTSKIY, A.G.,
RAAB, A.G.,
DANILKO, K.V.,
RAMESHBABU, N.,
VALIEV, R.Z. (2020) , E1 + RGD – titania PEO coating modified with integrin-active RGD (
arginine-glycine-aspartic acid
Parfenov, E,
Parfenova, L,
Mukaeva, V,
Farrakhov, R,
Stotskiy, A,
Raab, A,
Danilko, K,
Rameshbabu, N,
Valiev, R (2020) , E1- RGD titania PEO coating modified with integrin-active RGD (
arginine-glycine-aspartic acid
CHROMCHENKOVA, E.P.,
BOKOV, D.O.,
BESSONOV, V.V.,
SAMYLINA, I.A.,
KAKHRAMANOVA, S.D.,
CHEVIDAEV, V.V.,
SOKHIN, D.M.,
BALOBANOVA, N.P.,
EVGRAFOV, A.A.,
KRASNYUK, J.I.,
KUDASHKINA, N.V.,
GALIAKHMETOVA, E.K.,
MARAKHOVA, A.I.,
MOISEEV, D.V. (2020) a significant amount of
arginine, studies involving the prevention and adjunctive treatment of viral